Make Time Wellness, a brand founded by Emma Heming Willis, recently introduced three new products focused on women's brain health at the Natural Products Expo West. These offerings will launch on the company's website in April 2026.
Make Time Wellness' women's brain health formulations are dubbed Make Time for Menopause & Brain Health, Make Time for NAD+ & Rhodiola, and Make Time for Brain, Body, & Beauty Stick Packs. As the names might suggest, these are designed to address specific neurological and physiological needs women face during different life stages.
Make Time Wellness targets common but often dismissed issues like brain fog, cognitive fatigue, and hormonal fluctuations during perimenopause and menopause. The formulations include clinically studied ingredients such as Cognizin® Citicoline for cognitive function and memory, along with compounds like NAD+ and Rhodiola for cellular energy and stress adaptation.
Image Credit: Make Time Wellness
What Makes This Trend Stand Out
- Personalized Hormonal-cognitive Supplements
- Formulations tailored to hormonal status and cognitive symptoms create room for products that align nutrient ratios and dosages with individual menopausal profiles.
- Functional Ingredients Convergence
- Combining clinically studied nootropics like Citicoline with adaptogens and cellular energy compounds enables hybrid products addressing multiple biological pathways at once.
- Life-stage Focused Wellness Products
- Targeting perimenopause, menopause, and midlife transitions opens possibilities for product lines and delivery formats designed specifically around age-related cognitive and hormonal shifts.
Sectors Adopting This
- Nutraceuticals
- The growing demand for evidence-backed supplements creates scope for branded, clinically validated formulations marketed toward women’s cognitive aging.
- Women's Health Tech
- Digital platforms that integrate symptom tracking and biomarker data could inform personalized supplement recommendations and efficacy monitoring.
- Clinical Ingredient Supply
- Suppliers of patented, clinically studied compounds like Citicoline and NAD+ precursors stand to expand into co-branded ingredient partnerships and tailored dosage formats.
